Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.

http://www.wikidata.org/entity/Q37749714

about

Interventions for fatigue in Parkinson's disease Interventions for fatigue in Parkinson's disease Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.Reliability of the Brazilian Portuguese version of the fatigue severity scale and its correlation with pulmonary function, dyspnea, and functional capacity in patients with COPD Determinants of generic and specific health-related quality of life in patients with Parkinson's disease Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity.Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease.Neuroimaging and clinical predictors of fatigue in Parkinson disease Outcome measures for Parkinson's disease dementia: a systematic review.Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial Parkinson's Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer.Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson's disease patients.The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease.Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia.Nonmotor disturbances in Parkinson's disease.Fatigue in Parkinson's disease.Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.Wearing-off scales in Parkinson's disease: critique and recommendations.Fatigue assessment of Parkinson's disease patient in clinic: specific versus holistic.How to measure fatigue in neurological conditions? A systematic review of psychometric properties and clinical utility of measures used so far.Interventions for fatigue in Parkinson's disease: A systematic review and meta-analysis.A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations.Abnormal Resting-State Neural Activity and Connectivity of Fatigue in Parkinson's Disease.Attention in Parkinson's disease with fatigue: evidence from the attention network test.Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.The prevalence of fatigue following deep brain stimulation surgery in Parkinson's disease and association with quality of life.End of OSLER Test Sessions in Parkinson's Disease do not Correspond to True Sleep Onset: Results from an Exploratory Study.Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.Rigid patterns of effortful choice behavior after acute stress in rats.Basolateral amygdala supports the maintenance of value and effortful choice of a preferred option.Clinical Profile of Chinese Long-Term Parkinson's Disease Survivors With 10 Years of Disease Duration and Beyond.Parkinson disease with constipation: clinical features and relevant factors.

P2860

Q24186581-85B7D05B-1C49-43B6-8C70-6928D349D8D7 Q24201399-6BF4EA48-0B40-4EE5-A559-DE960181F869 Q24633747-0DC84E84-4999-4539-A420-80AF331FC03B Q26766222-2EBD3436-51B8-4C4C-A78D-A488BC96EC06 Q30250276-128BF0AC-0F13-4A0D-84BC-74CD86509205 Q33810138-8A2CE9DB-E307-4111-8527-3A2E90BA1CB4 Q33824156-FEBD2656-E961-4AAD-AD90-CF8DF7FE76DE Q33834634-E25D4FA0-4549-4C7F-A1F4-F77441ED5450 Q34174207-7CFC26B1-1E68-494F-991D-14CC4AB326E8 Q35431377-A2FB19C9-E305-48AC-8D69-C38C1EC7720D Q35564412-2661ACAF-17BE-4F3C-BE2A-102F766BED95 Q36494958-2E37B0B5-17B7-4041-A84B-68CAC4195F2F Q36688859-71E8568E-EF09-43B0-B16A-DD39F3940272 Q36689403-A7549400-22EF-4EA1-AF4A-5BB2E4BD1096 Q36789528-0678D768-5E2A-415A-985F-B0B0B12E08A5 Q36890229-0CC136D8-C804-4271-8A50-E4034CF417F5 Q36890515-63EE435D-BF8B-4F1F-B7AF-F977B9AF8A0F Q36943866-EB18AAF3-72C9-4B56-BCA7-6A019C110BE3 Q37191452-A089D9DC-F8E6-45A9-98F8-FA1F8611D7CC Q37302897-EE403888-1DE0-4BFA-9B34-2D856756E126 Q37360680-03B74912-5A27-4C00-AD87-15DA396DAF91 Q37825377-F5A8B192-E4B3-4E38-96F0-5BAC3B1BB411 Q37884077-62AB6671-23AA-4B87-AF3A-0CA1A2BFF0FC Q37898591-B04CE6F3-3337-43D0-879A-9303E1B4B495 Q37903795-44D726D0-855E-4337-AA8A-1C0834F6BD46 Q38077143-7D7CDC6B-B3F9-4BC5-9E97-1313160DC3B4 Q38187386-83E47942-4B40-4525-9CBE-FD9C7B7195DF Q38252415-FF766D5A-66D6-49FA-A0D4-9FEEC3DF96BE Q38697121-535633CC-9228-4613-871E-AF92F432E431 Q38761858-119D89DB-AAAF-4F81-B068-B0A5A262E85C Q39043547-9CBB97BC-36E3-49E5-9327-900FB43C78F4 Q39248105-554B6DE0-1D70-4E0F-AEFB-04E6C640EF0E Q39489438-4EACEE5F-FEE3-4F1E-AFD7-190DC0A944AE Q42177212-926D8673-FE33-4642-A7D1-C0C48FE800D6 Q43238494-78F303E9-106D-41B8-9633-AE2C0836E8F2 Q43994400-F6C3BE6B-36BA-4711-88A9-5DE8AA08064B Q45958542-FC3C1D26-DE57-4C45-BEEA-DF0B23919F3C Q46110222-AF6FBC69-E8DD-4A96-93BC-3C67AEFF4FCD Q47639038-355E1A3F-0E87-4C49-9FB9-D7A088C0C365 Q47645586-74FBCBAD-EAB1-477B-A3FD-36F4C03C9E95

P2860

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.

http://www.wikidata.org/entity/Q37749714

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fatigue rating scales critique ...... cales for Parkinson's disease.

@en

Fatigue rating scales critique ...... cales for Parkinson's disease.

@nl

type

label

Fatigue rating scales critique ...... cales for Parkinson's disease.

@en

Fatigue rating scales critique ...... cales for Parkinson's disease.

@nl

prefLabel

Fatigue rating scales critique ...... cales for Parkinson's disease.

@en

Fatigue rating scales critique ...... cales for Parkinson's disease.

@nl

P1433

Q37749714-01C520CE-CC9B-482B-99E1-7054FB89A78A

P1476

Q37749714-B9114DD1-ABE8-4294-9785-B28F3919D54D

P2093

Q37749714-22AB44CA-D898-4B03-B261-F09709D97D8D

Q37749714-55DB9693-51F5-4F7E-A8E3-DDC4DF4894B1

Q37749714-9D310185-7870-4217-A2CF-2508C6625F2E

Q37749714-9FDEF00E-5D93-4ED4-ABAB-C47C144B920D

Q37749714-A3315D19-F747-42C6-80E2-C947C4898230

P2860

Q37749714-0069B936-AE4D-4404-AE26-475200C98F92

Q37749714-08378C57-826D-4C4B-833F-1290927BC027

Q37749714-0C8B5D3B-0BE5-4079-BFA0-5A8229B43386

Q37749714-0D48586E-B7C6-4385-8514-41F440F8DC2E

Q37749714-0E9C0656-76B0-43A2-8F4C-EAD63C851803

Q37749714-10D89C87-9F3B-45A4-9420-94BCCA9A37D0

Q37749714-1372E8AC-0CD8-4B49-B263-6DFDFD78D551

Q37749714-1753E9E1-9BD2-48FB-ADEB-71C017A13EF7

Q37749714-17EE2085-15D4-494A-A3EE-B8775A413402

Q37749714-1CDD9B66-7EC2-46D0-AD9E-DDA8005261A9

P304

Q37749714-EFF5AC30-0EA9-4C41-82F0-3883198C96AA

P31

Q37749714-D0603656-B7AD-4748-AB59-77CB9A12A536

P356

Q37749714-E56E5474-9D3C-4040-9882-22BE9ABB526F

P407

Q37749714-316EDEE3-648E-4398-9E32-15F1BC45401C

P433

Q37749714-271691F1-1EDF-4611-8046-E48B172AA8B9

P478

Q37749714-D1EAF76B-0ACD-459F-BCF5-009432013A53

P50

Q37749714-0385B499-5498-4A48-BEC7-F46A41F4C363

Q37749714-30ECF4E6-B407-46C8-B463-1ACF492EE781

Q37749714-4DAA2813-3CDD-411B-BE9E-48C3E558C8F9

Q37749714-78979C61-003B-43B9-9BB5-451351B5948D

Q37749714-78DE000D-14B0-4F18-AC1C-96B07DC645ED

Q37749714-7DA67328-E961-489F-8735-1FCE2C701209

Q37749714-FDA384C7-595D-4F42-8896-162A4439FF58

P577

Q37749714-48FF5C33-9B4C-45FD-977D-0302239A7F9F

P5875

Q37749714-4AE0008E-288E-4A36-9648-679BDBD9466B

P698

Q37749714-ED46A27C-29BC-4365-825C-170FF3C8C262

P921

Q37749714-091087E3-B846-4CA3-82F2-2B05DF6AEA71

P356

P1433

Movement Disorders

P1476

Fatigue rating scales critique ...... cales for Parkinson's disease.

@en

P2093

Glenn Stebbins

http://www.w3.org/2001/XMLSchema#string

Guido Alves

http://www.w3.org/2001/XMLSchema#string

Johan Marinus

http://www.w3.org/2001/XMLSchema#string

Laura Marsh

http://www.w3.org/2001/XMLSchema#string

Peter Hagell

http://www.w3.org/2001/XMLSchema#string

P2860

The Magical Number Seven, Plus or Minus Two

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis

Effects of treatment for depression on fatigue in multiple sclerosis

Fatigue in levodopa-naive subjects with Parkinson disease.

The improved Clinical Global Impression Scale (iCGI): development and validation in depression

Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale.

Diurnal effects of motor activity and fatigue in Parkinson's disease.

Fatigue and basal ganglia.

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

P304

805-822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.22989

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Sampaio

Joseph H. Friedman

Pablo Martinez-Martin

Christopher G. Goetz

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44591460

http://www.w3.org/2001/XMLSchema#string

P698

20461797

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease